Detalles de la búsqueda
1.
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Cancer Immunol Immunother
; 73(6): 106, 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38634928
2.
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.
J Oncol Pharm Pract
; : 10781552241241004, 2024 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38613329
3.
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
Cancer Immunol Immunother
; 72(9): 2961-2970, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37248424
4.
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Cancer Immunol Immunother
; 72(11): 3665-3682, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676282
5.
Prognostic importance of SUVmax values evaluated by 18F-FDG-PET/CT before nivolumab treatment in patients with metastatic renal cell carcinoma.
Q J Nucl Med Mol Imaging
; 67(3): 223-229, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34881845
6.
Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium.
Urol Int
; 107(6): 595-601, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996793
7.
Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study.
Cancer Invest
; 40(2): 199-209, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34894960
8.
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study.
Future Oncol
; 18(23): 2573-2582, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35734870
9.
Response to first-line chemotherapy regimen is associated with efficacy of immune checkpoint blockade therapies in patients with metastatic urothelial carcinoma.
Int J Clin Oncol
; 27(3): 585-591, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34762201
10.
Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.
J Oncol Pharm Pract
; 28(1): 215-221, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34134568
11.
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database.
Future Oncol
; 17(35): 4861-4869, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34726480
12.
The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study.
Int J Clin Oncol
; 26(5): 826-834, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33486624
13.
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.
Int J Clin Oncol
; 26(8): 1506-1513, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023933
14.
Ribociclib induced acute kidney injury: A case report.
J Oncol Pharm Pract
; 27(8): 2023-2026, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33847193
15.
Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting?
J Oncol Pharm Pract
; 27(6): 1388-1394, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32847482
16.
Safe use of nivolumab in a patient with renal cell carcinoma and hepatitis B.
J Oncol Pharm Pract
; 26(4): 1022-1024, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31635548
17.
Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non-small-cell lung cancer.
J Clin Pharm Ther
; 45(2): 303-308, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31778239
18.
Long-lasting response with polycythemia to third-line axitinib treatment in metastatic renal cell carcinoma: Very rare case presentation.
J Oncol Pharm Pract
; 25(6): 1512-1515, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30058939
19.
Hepatitis B Reactivation Rate Is Higher Undergoing Some Cytotoxic Chemotherapy in Patients with Solid Tumors: A Large Retrospective Study.
Chemotherapy
; 63(5): 247-252, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30408779
20.
Lutetium-Associated Myopathy: A Case Report.
Am J Ther
; 2022 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35383588